Skip to main content
Clinical Trials/CTRI/2016/09/007270
CTRI/2016/09/007270
Recruiting
未知

A Cross-Sectional, Clinico-Epidemiological, Multicentre Study to Determine the Prevalence of Non-Alcoholic Fatty Liver Disease and Thyroid Dysfunction in Patients with Metabolic Syndrome, visiting the Endocrinology and Gastroenterology Out Patient Departments of Tertiary Health Care Centers in India.

Abbott India Limited0 sites400 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Patients with an established diagnosis of MetS as per the ATP III criteria and visiting the clinic as a part of their schedule
Sponsor
Abbott India Limited
Enrollment
400
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Male and female patients, aged 18 to 65 years inclusive
  • 2\.Patients with an established diagnosis of MetS as per the ATP III criteria and visiting the clinic as a part of their schedule

Exclusion Criteria

  • 1\.Patients with history of drug intake likely to cause NAFLD (e.g. aspirin, amiodarone, corticosteroids, methotrexate, 5\-fluorouracil, tamoxifen, valproate, zidovudine, didanosine, diltiazem) or TD (e.g. interferon, molecular\-targeted agents, amiodarone, thyroid hormone, anti\-thyroid drugs, lithium, iodine, dopamine)
  • 2\.Patients with history of jejuno\-ileal bypass or biliopancreatic diversion or extensive small bowel resection or total parenteral nutrition.
  • 3\.Evidence of other forms of chronic liver disease, suspected or confirmed hepatocellular carcinoma, known HIV positive
  • 4\.Female patients who are pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials